The Beat Pain Better Trial

Last updated: January 27, 2026
Sponsor: University of Utah
Overall Status: Active - Recruiting

Phase

3

Condition

Osteoarthritis

Pain

Chronic Pain

Treatment

Text Messaging

Motivational Messaging

Physical Activity Counseling and Self-Directed Walk with Ease

Clinical Study ID

NCT06932887
00182708
1U48DP006833
  • Ages > 45
  • All Genders

Study Summary

The Beat Pain Better study examines strategies to increase the reach of evidence-based interventions for persons with osteoarthritis (OA) in communities that experience disparities. The study is a hybrid type 3 effectiveness-imple-mentation trial using sequential, multiple assignment, ran¬domi¬zation to evaluate 1) two text mes¬saging strat¬egies to reach persons with OA and enroll them in physical activity counseling provided by physical therapists; and 2) two strat¬egies to engage enrolled persons in the Walk with Ease (WWE) intervention for sustained self-management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age 45 or older;

  2. Visit in participating medical clinic within the past 6 months

  3. OA diagnosis code related to lower extremity and/or spine on the problem list orassoci¬ated with an encounter in the past 6 months

  4. Has functioning cell phone able to receive calls and texts

Exclusion

Exclusion Criteria:

  1. Unable to participate in a regular walking program defined as the ability to walkfor at least five minutes with or without the use of an assistive device.

  2. Medical contraindication to participation in physical activity

  3. Unable to communicate in either Spanish or English

Study Design

Total Participants: 346
Treatment Group(s): 4
Primary Treatment: Text Messaging
Phase: 3
Study Start date:
May 28, 2025
Estimated Completion Date:
March 31, 2028

Study Description

We will conduct a hybrid type 3 effectiveness-imple¬mentation trial with a sequential, multiple assignment, ran¬domi¬zed design. Primary outcome is physical activity (PA) counseling reach (Aim 1). Secondary outcomes evaluate reach of WWE (Aim 2) and outcomes across RE-AIM domains (Aim 3). Persons with ICD-10 diagnosis codes indicating OA will be identified from EHRs in partnering clinics and sent text message (TM) invitations to participate in PA counseling. Phase I randomization will test two TM strategies: weekly TMs over 4 weeks with or without motiva¬tional messages. Phase II randomization for those who enroll in PA counseling and provide consent will test two formats for the WWE AAEBI; self-directed or enhanced self-directed delivery.

Participants will be randomized with 1:1 distribution at each randomization. Participants may consent and enroll for randomization to a WWE format even if they did not receive the TM intervention. The first randomization is performed using the TM platform (Azara or similar), stratified by site. The second randomization is performed using the REDCap randomization module, also stratified by site and by baseline PA level. Randomization schemas will be developed before enrollment. Randomization errors will be recorded as protocol deviations.

Connect with a study center

  • University of Utah

    Salt Lake City, Utah 84106
    United States

    Site Not Available

  • Association for Utah Community Health

    Salt Lake City 5780993, Utah 5549030 84107
    United States

    Active - Recruiting

  • University of Utah

    Salt Lake City 5780993, Utah 5549030 84106
    United States

    Site Not Available

  • Vamos Health

    West Valley City 5784607, Utah 5549030 84120
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.